Rhumbline Advisers »

Avalo Therapeutics Ord shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $985k 53k 18.48

More positions owned by Rhumbline Advisers

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Micron Technology (MU)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Visa (V)

View all positions for Rhumbline Advisers

Top funds holding Avalo Therapeutics Ord

FMR
BlackRock
Deep Track Capital
Caligan Partners
TCG Crossover Management
Affinity Asset Advisors
Farallon Capital Management
Point72 Asset Management
venBio Select Advisor
Vanguard Capital Management
BVF
Bank of America Corporation
Nantahala Capital Management
Adage Capital Partners GP
Soleus Capital Management

View all funds holding Avalo Therapeutics Ord